https://doi.org/10.55788/8a6d8084
Periodontitis, a common inflammatory and infectious disease of the gums, has been shown to aggravate some systemic diseases. Until now, the association of periodontitis with both atrial fibrosis, which contributes to the onset and persistence of AF, and AF remains unclear [1]. To elucidate a possible relationship between periodontitis and atrial fibrosis, Prof. Shunsuke Miyauchi (Hiroshima University, Japan) and his team studied resected left atrial appendages of 76 participants with AF following atrial appendage excision [2]. Additionally, all participants underwent an oral examination evaluating the remaining number of teeth, bleeding on probing (BOP), periodontal probing depth, and periodontal inflamed surface area (PISA). PISA depicts the sum of all the areas of bleeding in the periodontal pocket epithelium and reflects the quantification of clinical periodontal inflammation degree. In addition, the degree of left atrial appendage fibrosis was quantified histologically by Azan-Mallory staining in sections randomly resected from the distal side of each left atrial appendage.
The researchers found that 3 periodontitis-suggesting parameters were positively correlated with atrial fibrosis, namely BOP (R=0.48; P<0.0001), periodontal probing depth of >4 mm (r=0.26; P=0.02), and PISA (r=0.46; P<0.0001). Among patients with >10 remaining teeth, PISA was positively and strongly correlated with atrial fibrosis (r=0.57; P<0.0001). Also after adjusting the results for known risk factors of AF, such as age, AF duration, body mass index, mitral valve regurgitation, and CHADS₂ (congestive heart failure, hypertension, age, diabetes, previous stroke/transient ischemic attack) score, PISA was still significantly associated with atrial fibrosis (P=0.0002).
The authors concluded that there is a positive association of periodontitis with atrial fibrosis, especially in the presence of distinct inflammation. Periodontitis should be considered a modifiable risk factor for AF.
- Xintarakou A, et al. Europace. 2020;22(3):342–351
- Miyauchi S, et al. Relationship between periodontitis and atrial fibrosis in atrial fibrillation: Histological evaluation of left atrial appendages. EA.APS.P270, AHA Scientific Sessions 2022, Chicago, USA, 05–07 November.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« Idiopathic intracranial hypertension: key factors influencing visual outcomes Next Article
AF: Moderate alcohol intake possibly associated with a reduced mortality risk »
« Idiopathic intracranial hypertension: key factors influencing visual outcomes Next Article
AF: Moderate alcohol intake possibly associated with a reduced mortality risk »
Table of Contents: AHA 2022
Featured articles
What Is New in Heart Failure
Torsemide not superior to furosemide after hospitalisation for heart failure
IRONMAN failed primary endpoint but shows potential long-term benefits of iron repletion in HF patients
Up-titration of HF therapies following HF discharge saves lives
Hypertension: Novel Developments
The endothelin system: a new target for resistant high blood pressure
Can renal denervation lower BP on top of antihypertensive drugs?
Quadruple, ultra-low-dose treatment did not meet primary endpoint in hypertension
Mindfulness programme contributes to office blood pressure lowering
Interventional Cardiology in 2022
Grafting with the radial vein: an underrated option in CABG surgery?
Extracorporeal membrane oxygenation not superior to conservative therapy in cardiogenic shock
Surgery with adequate saphenous vein partly better than endovascular treatment in CLTI
Arrhythmia – State of the Art
First-line ablation limits progression to persistent AF
Doubling the dose of self-administered etripamil terminates PSVT
Novel Developments in Primary and Secondary Prevention
Grafting with the radial vein: an underrated option in CABG surgery?
Digitally delivered cognitive behavioural therapy successful in type 2 diabetes
Empagliflozin reduces risk of kidney disease progression and CV events in patients with CKD
RESPECT-EPA misses primary endpoint but hints towards improvements in CV outcomes by EPA
Pemafibrate fails to reduce cardiovascular events in diabetes but may benefit the liver
Dietary supplements not effective in lowering LDL-C, use of low-dose statins encouraged
No sex differences in lipid-lowering effect and treatment benefit of PCSK9 inhibitors
COVID-19 and the Heart
‘No’ to routine use of rivaroxaban in outpatients with COVID-19
COVID-19 pandemic: Older adults and those affected by the delta variant experienced increased cardiovascular morbidity and mortality
COVID-19 mRNA vaccination does not amplify risk of cardiovascular hospitalisation
Best of the Posters
Higher LDL-cholesterol levels linked to higher CVD mortality risk in the elderly
AF: Moderate alcohol intake possibly associated with a reduced mortality risk
Periodontitis: An independent risk factor for AF
Related Articles
January 11, 2023
Olpasiran leads to dramatic reductions in Lp(a) concentrations
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com